Skip to search formSkip to main contentSkip to account menu

OPC-1085

Known as: OPC 1085, OPC1085 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1978
1978
Cardiac electrophysiologic action of a new beta‐adrenergic blocking agent carteolol hydro‐chloride, or OPC‐1085, was studied in… 
1977
1977
The pharmacokinetics of 5-(3-tert.-butylamino-2-hydroxy)-propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol hydrochloride… 
1977
1977
The kinetics (absorption, distribution and excretion) of carteolol were investigated after oral and intravenous administration to… 
1977
1977
Effects of a newly synthesized beta-blocker, 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril (OPC-1085) were… 
1977
1977
1. The antiarrhythmic properties of 5–(3‐tert‐butylarnino‐2‐hydroxy)propoxy‐3,4‐dihydrocarbostyril hydrochloride (OPC‐1085) were… 
1977
1977
The effects of carteolol, propranolol and alprenolol were studied by using spontaneously contracting atria, atrial muscle and… 
1976
1976
Distribution of a new beta-adrenergic blocking agent, 3H-carteolol in mice was studied by whole body autoradiography. The… 
Highly Cited
1974
Highly Cited
1974
The beta-adrenergic blocking and hemodynamic properties of 5-(3-tert-butyl-amino-2-hydroxy) propoxy-3,4-dihydrocarbostyril…